CHAI is supporting the government of Vietnam to eliminate malaria, tuberculosis (TB), and hepatitis C, control COVID-19, and is exploring work in strengthening integrated grassroots health systems and non-communicable diseases such as diabetes and cancer.
Established in 2006 to fight HIV/AIDS, we are helping the government leverage COVID-19 antigen rapid tests to quickly identify and isolate infectious individuals among neglected populations and strengthen systems to reliably deliver medical oxygen to health facilities overstressed by the pandemic.
To expedite malaria elimination by 2027, we are helping to strengthen disease surveillance and case management and thereby help to end the global threat of drug resistance. We are also supporting the government scale up TB case finding innovations, introduce new treatment regimens such as BpaL (comprised of bedaquiline, pretomanid and linezolid) _, and enhance public-private engagements to help Vietnam reach its 2030 end TB goals. CHAI is also working to help eliminate hepatitis C, which infects about a million people in the country, by leveraging the national social health insurance system and Global Fund-procured drugs for treatment.
of children living with HIV receiving treatment in 2015
of children living with HIV surviving after 12 months of treatment in CHAI-supported provinces
people screened for tuberculosis using CHAI’s ACIS platform